Sleep Apnea: The Undiagnosed Epidemic
Sleep apnea affects 22 million Americans — but 80% are undiagnosed. Untreated sleep apnea increases the risk of cardiovascular disease by 2–3x, increases the risk of type 2 diabetes by 2x, and increases the risk of motor vehicle accidents by 2–3x. For employers with commercial drivers or other safety-sensitive employees, undiagnosed sleep apnea is a significant safety and liability risk.
Insomnia and CBT-I
Insomnia affects 30% of adults and is the most common sleep disorder. Cognitive behavioral therapy for insomnia (CBT-I) is the gold standard treatment — more effective than sleep medications and without the side effects. CBT-I is now available digitally through apps and online programs, making it accessible to employees who cannot attend in-person therapy.
Sleep Disorder Treatment Coverage
IQ Insight
Covering sleep disorder diagnosis and treatment is a high-ROI investment. A sleep apnea patient who receives CPAP therapy has 40% lower cardiovascular disease costs, 30% lower diabetes costs, and 50% lower accident rates. The cost of CPAP therapy ($500–$1,000) is far less than the cost of the cardiovascular events and accidents it prevents.